Skovronsky said he is most excited about treating more health conditions with GLP-1s and other incretin ... As chief ...

The big pharma sector is one that’s generally fallen out of favor for many investors over the past few decades, as large ...

The FDA has now resolved the shortages of Novo Nordisk and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

This comes after the FDA said in October that Eli Lilly weight-loss treatments Mounjaro and Zepbound (which use the active ingredient ... “FDA Clarifies Policies for Compounders as National GLP-1 ...

Demand GLP-1 Medications as Prescription Drug Market GrowsSchaumburg, Illinois, Feb 21, 2025 - (ACN Newswire) - Giftify, Inc.

Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, which in turn could put many ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) that helps regulate blood sugar levels. Because of outsized demand for ...

In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, ...

The Food and Drug Administration announced Friday it had officially declared an end to the nationwide shortage of Ozempic and ...